Table 1 Demographic and clinical variables of patients
Diagnosis | Number of patients | Gender (Female/Male) | Mean age at inclusion +/- SD (range) |
|---|---|---|---|
Group 1: NMO | 16 | 13/3 | 55.02 +/- 9.80 |
(40-63) | |||
Group 2: MS | 85 | 60/25 | 39.43 +/-9.40 |
(18-76) | |||
- Relapsing-remitting MS | 72 | ||
- Secondary progressive MS | 3 | ||
- Primary progressive MS | 10 | ||
Group 3: idiopathic ON | 24 | 17/7 | 35.01 +/- 11.39 |
(14-62) | |||
-Isolated episode | 15 | ||
-Recurrent idiopathic ON | 9 | ||
Group 4: idiopathic myelitis | 21 | 14/7 | 46.30 +/- 14.27 |
(21-68) | |||
-Isolated episode: | 18 | ||
> 3 vertebral segments | 9 | ||
≤ 3 vertebral segments | 9 | ||
-Recurrent idiopathic myelitis | 3 | ||
Group 5: other neurological disorders | 13 | 7/6 | 50.45 +/- 6.11 |
(42-59) | |||
-Myelitis associated with lupus | 2 | ||
-ON associated with Sjögren syndrome | 1 | ||
-Multifocal motor neuropathy | 2 | ||
-CIDP | 1 | ||
-Spinal infarction | 2 | ||
-Ischemic optic neuropathy | 5 | ||
Group 6: healthy controls | 8 | 5/3 | 34.45 +/- 8.31 |
(27-50) |